Segmental neurofibromatosis: is it uncommon or underdiagnosed? 1995

V Ingordo, and G D'Andria, and S Mendicini, and M Grecucci, and A Baglivo

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D017253 Neurofibromatoses A group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. NEUROFIBROMATOSIS 1 (generalized neurofibromatosis) accounts for approximately 95% of cases, although multiple additional subtypes (e.g., NEUROFIBROMATOSIS 2, neurofibromatosis 3, etc.) have been described. (From Neurochirurgie 1998 Nov;44(4):267-72) Neurofibromatosis,Neurofibromatosis Type 3,Multiple Neurofibromas,Neurofibromatosis 3,Neurofibromatosis Syndrome,Multiple Neurofibroma,Neurofibroma, Multiple,Neurofibromas, Multiple,Neurofibromatosis 3s,Neurofibromatosis Syndromes,Neurofibromatosis Type 3s,Syndrome, Neurofibromatosis,Syndromes, Neurofibromatosis,Type 3, Neurofibromatosis

Related Publications

V Ingordo, and G D'Andria, and S Mendicini, and M Grecucci, and A Baglivo
September 1997, Clinical and experimental dermatology,
V Ingordo, and G D'Andria, and S Mendicini, and M Grecucci, and A Baglivo
January 2017, Kardiologia polska,
V Ingordo, and G D'Andria, and S Mendicini, and M Grecucci, and A Baglivo
November 2010, Current vascular pharmacology,
V Ingordo, and G D'Andria, and S Mendicini, and M Grecucci, and A Baglivo
January 2015, Indian journal of dermatology, venereology and leprology,
V Ingordo, and G D'Andria, and S Mendicini, and M Grecucci, and A Baglivo
April 1992, Journal of the American Academy of Dermatology,
V Ingordo, and G D'Andria, and S Mendicini, and M Grecucci, and A Baglivo
January 1994, The British journal of dermatology,
V Ingordo, and G D'Andria, and S Mendicini, and M Grecucci, and A Baglivo
December 2020, Hematology/oncology and stem cell therapy,
V Ingordo, and G D'Andria, and S Mendicini, and M Grecucci, and A Baglivo
February 2010, European journal of pediatrics,
V Ingordo, and G D'Andria, and S Mendicini, and M Grecucci, and A Baglivo
September 2018, Revista espanola de cardiologia (English ed.),
V Ingordo, and G D'Andria, and S Mendicini, and M Grecucci, and A Baglivo
October 2011, Dermatology online journal,
Copied contents to your clipboard!